AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
Episode Description
This activity was supported by an educational grant from Vor Bio. Please go to http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.